Safety/Efficacy Study of 2nd Cycle Treatment After 6 Months of 1st Cycle HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in ALS
Clinical trial NCT03214146 · UNKNOWN
Trial details
- NCT number
- NCT03214146
- Sponsor
- Hanyang University Seoul Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-01
- Primary completion
- 2019-03-25
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.